Lung transplantation in children following treatment for malignancy

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 154-160

  Pechet, Taine V ^a   De Le Morena, Maite ^a   Mendeloff, Eric N ^a   Sweet, Stuart C ^a   Shapiro, Steven D ^a   Huddleston, Charles B ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; ARABINOSIDE; ASPARAGINASE; AZATHIOPRINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE GRAFT REJECTION; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASPERGILLUS; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS; BRONCHITIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; MEDULLOBLASTOMA; MYCOBACTERIUM CHELONEI; OPPORTUNISTIC INFECTION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUKEMIA; LUNG TRANSPLANTATION; MALE; MEDULLOBLASTOMA; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037314345     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00671-X     Document Type: Article

References (18)

1. Armitage J.M., Kormos R.L., Griffith R.P., Fricker F.J., Hardesty R.L. Heart transplantation in patients with malignant disease. J Heart Transplant. 9:1990;627-630.
2. Kelly D.M., Emre S., Guy S.R., Miller C.M., Schwartz M.E., Sheiner P.A. Liver transplant recipients are not at increased risk for nonlymphomic organ donors. Cancer. 83:1998;1237-1243.
3. Butcher J.A., Hariharan S., Adams M.B., Johnson C.P., Roza A.M., Cohen E.P. Renal transplantation for end-stage renal disease following bone marrow transplantation a report of six cases, with and without immunosuppression. Clin Transplant. 13:1999;330-335.
4. Huddleston C.B., Sweet S.C., Cohen A.H., et al. Bronchiolitis obliterans after pediatric lung transplantation. J Heart Lung Transplant. 17:1998;65.
5. Cooper A.D., White D.A., Muthay P.A. Drug-induced pulmonary disease. Am Rev Respir Dis. 133:1986;321-340.
6. Morgan G.W., Pharm B., Breit S.N. Radiation and the lung a reevaluation of the mechanisms mediating pulmonary injury. In J Radiol Oncol Biol Phys. 13:1987;179.
7. Chan C.K., Hyland R.H., Hutcheon M.A. Pulmonary complications following bone marrow transplantation. Clin Chest Med. 11:1990;323-332.
8. Clark J.G., Crawford S.W., Madtes D.K., Sullivan K.M. Obstructive lung disease after allogeneic marrow transplantation. Ann Intern Med. 111:1989;368-376.
9. Ettinger N.A., Trulock E.P. Pulmonary considerations of organ transplantation. Am Rev Respir Dis. 144:1991;213-223.
10. Sullivan K.M., Deeg H.J., Sanders J.E., et al. Late complications after marrow transplantation. Semin Hematol. 21:1984;53.
11. Urbanski S.J., Kossakowska A.E., Curtis J., et al. Idiopathic small airways pathology in patients with graft-versus-host disease following allogenic bone marrow transplantation. Am J Surg Pathol. 11:1987;965-971.
12. Clark J.G., Schwartz D.A., Flournoy N., Sullivan K.M., Crawford S.W., Thomas E.D. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med. 107:1987;648-656.
13. Kaplan E.B., Wodell R.A., Wilmott R.W., et al. Chronic graft-versus-host disease and pulmonary function. Pediatr Pulmon. 14:1992;141-148.
14. Abbas A.K., Lichtman A.H., Pober J.S. Transplantation immunology. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and molecular immunology. 2000;381-383 Saunders, Philadelphia.
15. Kapoor S., Kurland G., Jakacki R. Recurrent medulloblastoma following pediatric double-lung transplant. J Heart Lung Transplant. 19:2000;1011-1013.
16. Garver R.I., Zorn G.L., Wu X., et al. Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N Engl J Med. 340:1999;1071-1074.
17. Calhoon J.H., Levine S., Anzueto A., Bryan C.L., Trinkle J.K. Lung transplantation in a patient with a prior bone marrow transplant. Chest. 102:1992;948-949.
18. Boas S.R., Noyes B.E., Kurland G.K., Armitage J., Orenstein D. Pediatric lung transplantation for graft-versus-host disease following bone marrow transplantation. Chest. 105:1994;1584-1586.